·
2 Min Read

May 17, 2018: Advocacy spotlight on Trump Administration releases drug pricing blueprint

Trump Administration releases drug pricing blueprint; AMA and Federation members are looking into impact on specialty treatments and other concerns.

Advocacy Update
·
4 Min Read

May 17, 2018: National Advocacy Update

Bills to address opioid abuse, VA Choice reform bill and more in the latest AMA national health care advocacy news.

Advocacy Update
·
5 Min Read

May 17, 2018: State Advocacy Update

Medicaid waivers, Medicaid expansion, and more in AMA's latest state and local advocacy efforts.

Advocacy Update
·
1 Min Read

AMA President Barbe applauds Trump effort on prescription drug prices

The AMA is pleased the Trump administration is moving forward with its effort to address seemingly arbitrary pricing for prescription drugs.

Press Releases
·
2 Min Read

May 3, 2018: State Advocacy Update

AMA testifies on opioids and artificial intelligence and a change in buprenorphine MME display in the latest AMA state advocacy efforts.

Advocacy Update
Two physicians fill out paperwork at a table.
·
4 Min Read

Wider use of proven treatment is goal of opioid-use disorder APM

A new alternative payment model for treatment of opioid-use disorder is designed to support coordinated delivery of medical, psychological and social services.

Payment & Delivery Models
7 Min Read

AMA model bills

View the most frequently used model state bills created for the Federation of Medicine and approved by the AMA Board of Trustees.

State Advocacy
·
2 Min Read

AMA urges participation in National Prescription Drug Take Back Day

The AMA urges anyone who has unused, unwanted, and expired prescription medications to drop them off at one of the thousands of drop-off sites on April 28.

Press Releases
·
3 Min Read

AMA sees progress in declining opioid prescriptions

After IQVIA announced a 22% decline in opioid prescriptions between 2013-2017, the AMA see progress but urges continued focus on evidence-based treatment.

Press Releases